AGP Executive Report
Last update: 2 hours agoDrug Safety: Unapproved peptide injections drove 1,180 emergency visits across Australia’s largest health system from July 2025 to September 2026; one-quarter involved people aged 16 to 24. Multiple Sclerosis: A phase 3 pediatric study found MRI benefits with ocrelizumab versus fingolimod, supporting use of the treatment in children with relapsing MS. Global Access: A campaign marking healthcare as a human right highlighted that 4.6 billion people lack coverage for essential health services. Smoking Cessation: In a trial of patients referred for lung cancer screening, medication plus financial incentives helped 8.8% quit after six months, compared with 4.3% receiving standard care. Care Coordination: Nigerian health leaders called for stronger referrals and information sharing so patients aren’t left to manage fragmented care themselves. Ebola Response: DR Congo has begun vaccinating healthcare and emergency workers, as Kenya reports infections among health staff.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
